4554.T
Fuji Pharma Co.,Ltd.
プライム · 医薬品 · 医薬品 · JP
JPY 1,755.00
−0.45%Year over year
Reported trailing growth
- Revenue
- +17.3%
- EBITDA
- —
- EBIT
- +49.4%
- EPS
- -24.1%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +3.4%
- EBITDA
- —
- EPS
- -7.7%
Three-year CAGR
- Revenue
- +13.4%
- EBITDA
- +12.4%
- EBIT
- +9.7%
- Net income
- +3.6%
- EPS
- +3.5%
- Free cash flow
- +178.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026